Discover
NKTR
Nektar Therapeutics
41.17
1 x 33.61
1 x 44.36
bid
ask
+
0.37
0.91%
1 @ 05:34 PM
41.17 +0.00 (0.00%)
| Ytd | -2.63% | |
| 1y | -26.01% |
40.38
day range
42.38
35.12
52 week range
100.35
| Open | 40.38 | Prev Close | 40.80 | Low | 40.38 | High | 42.38 | Mkt Cap | 1.41B |
| Vol | 1.17M | Avg Vol | 1.07M | EPS | -17.58 | P/E | N/A | Forward P/E | -4.04 |
| Beta | 1.27 | Short Ratio | 8.82 | Inst. Own | 107.12% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 67.07 | 200-d Avg | 65.30 | 1yr Est | 141.40 |
| Income Statement | |||
| Total Revenue | 10.13M | ||
| Revenues (USD) | 10.13M | ||
| Gross Profit | 10.13M | ||
| Operating Expenses | 52.47M | ||
| Research and Development Expense | 39.13M | ||
| Selling, General and Administrative Expense | 12.77M | ||
| Operating Income | -42.34M | ||
| Interest Expense | 7.21M | ||
| Income Tax Expense | 2.00K | ||
| Net Income | -40.62M | ||
| Net Income Common Stock | -40.62M | ||
| Net Income Common Stock (USD) | -40.62M | ||
| Consolidated Income | -40.62M | ||
| Earnings per Basic Share | -1.23 | ||
| Earnings per Basic Share (USD) | -1.23 | ||
| Earnings per Diluted Share | -1.23 | ||
| Earning Before Interest & Taxes (EBIT) | -33.41M | ||
| Earning Before Interest & Taxes (USD) | -33.41M | ||
| Weighted Average Shares | 33.05M | ||
| Weighted Average Shares Diluted | 33.05M | ||
| Balance Sheet | |||
| Cash and Equivalents | 39.27M | ||
| Cash and Equivalents (USD) | 39.27M | ||
| Investments | 984.14M | ||
| Investments Current | 645.07M | ||
| Investments Non-Current | 339.06M | ||
| Current Assets | 739.40M | ||
| Total Assets | 1.10B | ||
| Debt Current | 22.71M | ||
| Total Debt | 78.56M | ||
| Current Liabilities | 70.99M | ||
| Debt Non-Current | 55.85M | ||
| Total Liabilities | 192.01M | ||
| Accumulated Retained Earnings (Deficit) | -3.85B | ||
| Accumulated Other Comprehensive Income | -1.76M | ||
| Shareholders Equity | 903.12M | ||
| Shareholders Equity (USD) | 903.12M | ||
| Assets Non-Current | 355.73M | ||
| Total Debt (USD) | 78.56M | ||
| Liabilities Non-Current | 121.02M | ||
| Trade and Non-Trade Payables | 24.89M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 156.00K | ||
| Net Cash Flow from Financing | 364.57M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -110.31M | ||
| Capital Expenditure | -94.00K | ||
| Issuance (Purchase) of Equity Shares | 364.57M | ||
| Net Cash Flow from Investing | -399.11M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -399.02M | ||
| Net Cash Flow from Operations | -75.77M | ||
| Share Based Compensation | 3.37M | ||